Cat. No.: X24-05-ZQ282
AMPK inhibitor BML-275, Purity ≥98%
Synonym: 866405-64-3; BML275; BML 275; Dorsomorphin; AMPK inhibitor
- CAS Number: 866405-64-3
- Compound CID: 11524144
Properties
Description
BML-275, soluble in warmed DMSO and warmed ethanol and insoluble in water, downregulates metabolic and energy homeostasis pathways, affecting cellular energy balance and potentially influencing cancer and metabolic disorders. It targets AMPK.
Molecular Weight
399.5
Molecular Formula
C24H25N5O
Targets
AMPK: 109 nM (Ki)
Form
Lyophilized powder
Purity
≥98%
Solubility
Warmed DMSO: 1 mg/mL (2.5 mM); Water: Insoluble; Warmed ethanol: 2 mg/mL
Identity
Confirmed by NMR/HPLC/MS.
Applications
BML-275 is used to inhibit AMPK and study its impact on metabolic pathways and cancer.
Publications
Publications (0)
×
Publications
Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.
As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.
*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.
- AMPK inhibitor A-769662, Purity ≥98%
- AMPK inhibitor ASP4132, Purity ≥98%
- AMPK inhibitor Dorsomorphin 2HCl, Purity ≥98%
- AMPK inhibitor ETC-1002, Purity ≥98%
- AMPK inhibitor ex229, Purity ≥98%
- AMPK inhibitor GSK621, Purity ≥98%
Quick Links
PRODUCTS
GalNAc-L96 intermediate, T1 (Cat#: X24-11-YM010)
GalNAc-L96 intermediate, T2 (Cat#: X24-11-YM011)
GalNAc-L96 intermediate, T3 (Cat#: X24-11-YM012)
GalNAc-L96 intermediate, T4-Amine (Cat#: X24-11-YM014)
Tri-GalNAc(OAc)3 Cbz (Cat#: X24-11-YM015)
Tri-GalNAc(OAc)3 (Cat#: X24-11-YM016)
Tri-GalNAc(OAc)3 TFA (Cat#: X24-11-YM017)
GalNAc-L96-OH (Cat#: X24-11-YM018)
GalNAc-L96-TEA (Cat#: X24-11-YM019)
Neu5Gcα(2-6)N-Glycan (Cat#: X23-03-YW036)
A2G2 N-Glycan (Cat#: X23-03-YW037)
A2G2S2 N-Glycan (Cat#: X23-03-YW038)
A2 N-Glycan (Cat#: X23-03-YW039)
A2[6]G1 N-Glycan (Cat#: X23-03-YW040)
M3 N-Glycan (Cat#: X23-03-YW041)
A2[3]G2S1 N-Glycan (Cat#: X23-03-YW042)
Core 2 O-glycan, Ser-Fmoc linked (Cat#: X23-10-YW178)
Core 2 O-glycan, Thr-Fmoc linked (Cat#: X23-10-YW179)
Core 3 O-glycan, Ser-Fmoc linked (Cat#: X23-10-YW180)
Core 3 O-glycan, Thr-Fmoc linked (Cat#: X23-10-YW181)
Core 4 O-glycan, Ser-Fmoc linked (Cat#: X23-10-YW182)
T antigen O-glycan, Ser-Fmoc linked (Cat#: X23-10-YW192)
T antigen O-glycan, Thr-Fmoc linked (Cat#: X23-10-YW193)
Tn antigen O-glycan, Ser-Fmoc linked (Cat#: X23-10-YW194)
Blood group A trisaccharide (Cat#: XCO0060Q)
Blood group B trisaccharide (Cat#: XCO0068Q)
Blood group H disaccharide (Cat#: XCO0074Q)
Lewis A trisaccharide (Cat#: XCO0079Q)
3'-Sulfated lewis A (Cat#: XCO0080Q)
Lewis B tetrasaccharide (Cat#: XCO0083Q)
Lewis X trisaccharide (Cat#: XCO0085Q)
Lewis Y tetrasaccharide (Cat#: XCO0088Q)
Lacto-N-biose (Cat#: XCO0089Q)
2'-Fucosyllactose (Cat#: XCO0091Q)
3-Fucosyllactose (Cat#: XCO0092Q)
Lactodifucotetraose (Cat#: XCO0093Q)
Lacto-N-triose I (Cat#: XCO0094Q)
3'-Sialyllactose sodium salt (Cat#: XCO0096Q)
6'-Sialyllactose sodium salt (Cat#: XCO0098Q)
3'-Sialyl-3-fucosyllactose (Cat#: XCO0100Q)
Heparin amine, MW 27 kDa (Cat#: X22-09-ZQ478)
FITC-heparin, MW 27 kDa (Cat#: X22-09-ZQ480)
TRITC-heparin, MW 27 kDa (Cat#: X22-09-ZQ481)
Biotin-heparin-FITC, MW 18 kDa (Cat#: X22-09-ZQ482)
Chondroitin sulfate (dp4) (Cat#: X22-11-ZQ598)
Dermatan sulfate (dp12) (Cat#: X22-11-ZQ611)
Heparin disaccharide I-A (Cat#: X22-11-ZQ662)
Chondroitine sulfate (Cat#: X23-04-XQ1118)
GalNAcβ(1-4)GlcNAcβ-Sp3-Biotin (Cat#: X22-12-ZQ005)
GalNAcβ(1-4)GlcNAcβ-Sp3-PAA-Biotin (Cat#: X22-12-ZQ006)
GalNAcβ(1-4)GlcNAcβ-Sp3-PAA-FITC (Cat#: X22-12-ZQ007)
GalNAcβ(1-4)GlcNAcβ-Sp3-PAA (Cat#: X22-12-ZQ008)
Glcβ(1-4)GalNAcα-Sp3-Biotin (Cat#: X22-12-ZQ037)
Glcβ(1-4)GalNAcα-Sp3-PAA-Biotin (Cat#: X22-12-ZQ038)
Glcβ(1-4)GalNAcα-Sp3-PAA-FITC (Cat#: X22-12-ZQ039)
Glcβ(1-4)GalNAcα-Sp3-PAA (Cat#: X22-12-ZQ040)
GlcCer (d18:1/8:0) (Cat#: X23-11-ZQ101)
GalCer (d18:1/16:0) (Cat#: X23-11-ZQ112)
LacCer (d18:1/8:0) (Cat#: X23-11-ZQ118)
Lc3Cer (d18:1/8:0) (Cat#: X23-11-ZQ131)
Lc4Cer (d18:1/12:0) (Cat#: X23-11-ZQ146)
Sialyl-Lc4Cer (d18:1/18:0) (Cat#: X23-11-ZQ162)
Lewis a Cer (d18:1/16:0) (Cat#: X23-11-ZQ175)
nLc4Cer (d18:1/18:0) (Cat#: X23-11-ZQ190)
Methyl-γ-cyclodextrin (DS 12) (Cat#: X23-11-YM119)
Carboxymethyl-ɑ-cyclodextrin sodium salt (Cat#: X23-11-B003)
Carboxymethyl-γ-cyclodextrin sodium salt (Cat#: X23-11-B004)
Succinyl-ɑ-cyclodextrin (Cat#: X23-11-B005)
Succinyl-γ-cyclodextrin (Cat#: X23-11-B006)
ɑ-Cyclodextrin sulfate sodium salt (Cat#: X23-11-B007)
β-Cyclodextrin sulfate sodium salt (Cat#: X23-11-B008)
γ-Cyclodextrin sulfate sodium salt (Cat#: X23-11-B009)
Lysine-dextran, MW 4 kDa (Cat#: X22-09-ZQ273)
Phenyl-dextran, MW 150 kDa (Cat#: X22-09-ZQ279)
FITC-Q-dextran, MW 10 kDa (Cat#: X22-09-ZQ280)
FITC-lysine-dextran, MW 10 kDa (Cat#: X22-09-ZQ283)
TRITC-lysine-dextran, MW 10 kDa (Cat#: X22-09-ZQ287)
FITC-dextran sulfate, MW 10 kDa (Cat#: X22-09-ZQ291)
Dextran amine, MW 20 kDa (Cat#: X22-09-ZQ377)
TRITC-dextran, MW 40 kDa (Cat#: X22-09-ZQ383)
Biotin-dextran-FITC, MW 20 kDa (Cat#: X22-09-ZQ389)
Online Inquiry